Clinical Trial Update: A Randomized, Placebo-Controlled, Double-Blind Pilot Study of Pioglitazone Hydrochloride in Severe, Refractory Asthma [Phase 2]

View source ↗

Summary

A Phase 2 randomized, placebo-controlled pilot study evaluating pioglitazone hydrochloride in adults with severe, refractory asthma has been completed with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Airflow Obstruction
• Asthma
• Asthma with Airway Inflammation

Drugs mentioned

• Pioglitazone hydrochloride (Pioglitazone hydrochloride)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Severe, Refractory Asthma, Airway Inflammation | Phase 2 | Status: COMPLETED | Results posted: 2017-09-05